Page last updated: 2024-11-11

3,3'-dihexyl-2,2'-oxacarbocyanine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3,3'-dihexyl-2,2'-oxacarbocyanine: a fluorescent probe [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5702703
SCHEMBL ID16867337
MeSH IDM0402508

Synonyms (14)

Synonym
3-hexyl-2-(3-(3-hexyl-2(3h)-benzoxazolylidene)-1-propenyl)benzoxazolium
(2e)-3-hexyl-2-[(e)-3-(3-hexyl-1,3-benzoxazol-3-ium-2-yl)prop-2-enylidene]-1,3-benzoxazole
54501-79-0
unii-v7mkn24yhg
3,3'-dihexyl-2,2'-oxacarbocyanine
nk 2280
3,3'-dihexaoxycarbocyanine iodide
3,3'-dihexyl-2,2'-oxycarbocyanine
benzoxazolium, 3-hexyl-2-(3-(3-hexyl-2(3h)-benzoxazolylidene)-1-propenyl)-
v7mkn24yhg ,
SCHEMBL16867337
DTXSID80866308
benzoxazolium, 3-hexyl-2-[3-(3-hexyl-2(3h)-benzoxazolylidene)-1-propen-1-yl]-
3-hexyl-2-[3-(3-hexyl-2(3h)-benzoxazolylidene)-1-propen-1-yl]benzoxazolium

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" The mean dose-response curves for apoptosis of six healthy volunteers obtained with both methods were steep below 1 Gy and flatter at higher doses."( Flow cytometry as a quantitative and sensitive method to evaluate low dose radiation induced apoptosis in vitro in human peripheral blood lymphocytes.
Cornelissen, M; De Ridder, L; Hertveldt, K; Philippé, J; Thierens, H; Vral, A, 1997
)
0.3
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (134)

TimeframeStudies, This Drug (%)All Drugs %
pre-199014 (10.45)18.7374
1990's50 (37.31)18.2507
2000's53 (39.55)29.6817
2010's15 (11.19)24.3611
2020's2 (1.49)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 9.85

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index9.85 (24.57)
Research Supply Index4.97 (2.92)
Research Growth Index4.82 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (9.85)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (2.10%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other140 (97.90%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]